Deals Shaping The Medical Industry, June 2020
Derived from Biomedtracker, the Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
You may also be interested in...
Danes Advise Pharma Firms To Test Their Anti-Tamper Devices
About 10% of marketed medicines chosen at random in Denmark had “non-functioning” anti-tamper devices, leaving them open to possible interference.
Biogen Chases Fresenius After Revealing EU Tocilizumab Nod
Ahead of the EMA’s CHMP publishing its April meeting highlights, Biogen has revealed a positive opinion for its Tofidence biosimilar tocilizumab rival to RoActemra. However, Fresenius already has a version on the market.
Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials
Real-world evidence and patient involvement can help developers shore up evidence from single arm trials for EU-wide joint clinical assessments.
| Table |
|---|